drugset

drugset / Trial / NCT04879134

Apomorphine Effects on Pain in Parkinson's Disease

NCT04879134 ↗

Phase 2/3 Unknown 40 enrolled University of Calgary Paladin Labs Inc. · collab

RandomizedCrossoverTriple-blindTreatment

Summary

To study the effects of acute apomorphine vs. placebo administration on different Parkinson's disease pain types.

Timeline

Start: 2022-02-28
Primary completion: 2023-02
Completion: 2023-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Apomorphine	Unknown	5 mg	Other

Indications